Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Pediatría | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2 Open-Label Study in Infants With REspiratory Syncytial VIRus Lower RespirAtory Tract Infection, Followed by a DoubLe-blind, Placebocontrolled Part, to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Effect of RV521 (REVIRAL 1)
INTERVENTIONAL
Inicio: 13 de nov de 2019
ID: NCT04225897
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Open-Label Trial of Intravenous Golimumab, a Human Anti-TNFα Antibody, in Pediatric Subjects With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy
INTERVENTIONAL
Inicio: 22 de dic de 2014
ID: NCT02277444
Activo, no recluta
Fase 3
ClinicalTrials.gov
Oral Amoxicillin Compared to Penicillin G Benzathine for the Treatment of Acquired Syphilis in Pediatric Population: Prospective, Open-label, Non-inferiority, Multicenter Trial
INTERVENTIONAL
Inicio: 14 de ago de 2024
ID: NCT06877351
Completado
Fase 2
ClinicalTrials.gov
An Open-label Study of Liquid and Sprinkled Formulations of Efavirenz Administered in Combination With Didanosine and Emtricitabine in HIV-infected Infants and Children 3 Months to 6 Years of Age.
INTERVENTIONAL
Inicio: 1 de feb de 2007
ID: NCT00364793
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy ≥4 Years to <17 Years of Age With Partial Onset Seizures
INTERVENTIONAL
Inicio: 29 de ago de 2013
ID: NCT01921205
Completado
Fase 3
ClinicalTrials.gov
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00891046
Completado
Fase 3
ClinicalTrials.gov
Open Label, Two Cohort (With and Without Imiglucerase), Multicenter Study to Evaluate Pharmacokinetics, Safety, and Efficacy of Eliglustat in Pediatric Patients With Gaucher Disease Type 1 and Type 3
INTERVENTIONAL
Inicio: 11 de abr de 2018
ID: NCT03485677
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 1/2 Open-label Study to Investigate the Safety, Efficacy, and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) and Minimal Residual Disease Positive (MRD+) B-ALL
INTERVENTIONAL
Inicio: 4 de ene de 2021
ID: NCT04521231
Completado
Fase 2
ClinicalTrials.gov
A 48 Week, Phase II, Open-label, 2-cohort, Multicenter Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Antiviral Activity of GW433908 and GW433908/RTV When Administered to HIV-1 Infected Protease Inhibitor (PI) Naive and PI-experienced Pediatric Subjects Aged 4 Weeks to <2 Years.
INTERVENTIONAL
Inicio: 23 de oct de 2003
ID: NCT00071760
Completado
Fase 3
ClinicalTrials.gov
Randomized, Controlled, Parallel, Prospective Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects, as Applicable, Compared to That of Episodic Treatment
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00623480
Completado
ClinicalTrials.gov
Multicenter Study to Reduce Adverse Events in Pediatric Intensive Care Units in Argentina Using a Program to Improve the Transfer of Patients
INTERVENTIONAL
Inicio: 15 de jul de 2018
ID: NCT03924570
Desconocido
ClinicalTrials.gov
Effect of Bilateral Spinae Erector Block (ESP) and Perioperative Gabapentin on Recovery and Length of Stay in Adolescent Spinal Fusion Patients: A Retrospective Cohort Stud
OBSERVATIONAL
Inicio: 1 de ago de 2023
ID: NCT06096480
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Observer-blind, Phase 2 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Dose Levels of Ad26.COV2.S Administered as a One- or Two-dose Regimen in Healthy Adolescents From 12 to 17 Years Inclusive
INTERVENTIONAL
Inicio: 27 de sept de 2021
ID: NCT05007080
Activo, no recluta
ClinicalTrials.gov
Assessment of Children and Adolescents With Asthma: An Observational Prospective Study
OBSERVATIONAL
Inicio: 26 de jul de 2017
ID: NCT04480242
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Oral Rilzabrutinib (PRN1008) in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
INTERVENTIONAL
Inicio: 14 de dic de 2020
ID: NCT04562766
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension
INTERVENTIONAL
Inicio: 18 de oct de 2019
ID: NCT03958877
Reclutando
Fase 3
ClinicalTrials.gov
Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine
INTERVENTIONAL
Inicio: 1 de dic de 2021
ID: NCT05164172
Completado
Fase 3
ClinicalTrials.gov
A Multicentre, Randomized, Double-blind, Parallel Group, Placebocontrolled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Asthmatic Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist (CALIMA)
INTERVENTIONAL
Inicio: 1 de ago de 2013
ID: NCT01914757
Retirado
Fase 2
ClinicalTrials.gov
Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa, Etoposide and Carboplatin) and Autologous Stem Cell Rescue
INTERVENTIONAL
Inicio: 1 de nov de 1997
ID: NCT00003273
Completado
Fase 2
ClinicalTrials.gov
Phase-II Immunogenicity Study of a DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO at 2, 4, and 6 Months of Age in Healthy Argentinean Infants
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00831311
Anterior
1
...
22
23
24
...
434
Siguiente
Filtros